Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 117 (4) , 918-925
- https://doi.org/10.1016/s0016-5085(99)70351-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- Ursodeoxycholic Acid Treatment in Patients with Primary Biliary Cirrhosis: A Swedish Multicentre, Double-Blind, Randomized Controlled StudyScandinavian Journal of Gastroenterology, 1997
- Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosisJournal of Hepatology, 1996
- Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisJournal of Hepatology, 1994
- Oral Budesonide for Active Crohn's DiseaseNew England Journal of Medicine, 1994
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- Oral budesonide in active Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989